Human glioma cells transformed by IGF-I triple helix technology show immune and apoptotic characteristics determining cell selection for gene therapy of glioblastoma.

Source:http://linkedlifedata.com/resource/pubmed/id/11477137

Download in:

View as

General Info

PMID
11477137